MetaADEDB 2.0 @ LMMD
gadolinium ethoxybenzyl DTPA
(PCZHWPSNPWAQNF-LMOVPXPDSA-K)
Structure
SMILES
CCOc1ccc(cc1)C[C@H](N(CC(=O)[O-])CC(=O)[O-])CN(CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Gd+3].[H+].[H+]
Type(s)
Approved
ATC code(s)
V08CA10
Molecular Formula:
C23H28GdN3O11
Molecular Weight:
681.748
Log P:
-7.3481
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
0
TPSA:
219.6
CAS Number(s):
135326-11-3
Synonym(s)
1.
gadolinium ethoxybenzyl DTPA
2.
Eovist
3.
Gd-EOB-DTPA
4.
Primovist
5.
disodium gadoxetate
6.
gadolinium (4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic acid disodium salt
7.
gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid
8.
gadoxetate disodium
9.
gadoxetic acid
10.
gadoxetic acid disodium
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 13SIDER
US FAERS
2MalaiseFAERS: 8SIDER
US FAERS
3UrticariaFAERS: 5SIDER
US FAERS
4VomitingFAERS: 5SIDER
US FAERS
5ChillsFAERS: 4SIDER
US FAERS
6DizzinessFAERS: 4SIDER
US FAERS
7HypotensionFAERS: 4SIDER
US FAERS
8Unresponsive to stimuliFAERS: 4US FAERS
9Adverse eventFAERS: 3US FAERS
10Chest discomfortFAERS: 3US FAERS
11Cold sweatFAERS: 3US FAERS
12ErythemaFAERS: 3US FAERS
13Respiratory arrestFAERS: 3US FAERS
14AmnesiaFAERS: 2US FAERS
15Anaphylactoid ReactionFAERS: 2SIDER
US FAERS
16AnxietyFAERS: 2US FAERS
17Burning sensationFAERS: 2US FAERS
18CyanosisFAERS: 2US FAERS
19DisorientationFAERS: 2US FAERS
20Electromechanical dissociationFAERS: 2US FAERS
21PresyncopeFAERS: 2US FAERS
22PruritusFAERS: 2SIDER
US FAERS
23Urinary IncontinenceFAERS: 2US FAERS
24Abdominal PainFAERS: 1SIDER
US FAERS
25AngioedemaFAERS: 1US FAERS
26AphasiaFAERS: 1US FAERS
27ArthralgiaFAERS: 1US FAERS
28AsthmaFAERS: 1US FAERS
29Blood creatinine increasedFAERS: 1US FAERS
30BradycardiaFAERS: 1US FAERS
31BronchospasmFAERS: 1US FAERS
32Cardiac ArrestFAERS: 1US FAERS
33Cardiovascular insufficiencyFAERS: 1US FAERS
34Chest PainFAERS: 1SIDER
US FAERS
35ChokingFAERS: 1US FAERS
36Contrast media reactionFAERS: 1US FAERS
37DementiaFAERS: 1US FAERS
38Drug ineffectiveFAERS: 1US FAERS
39DyspepsiaFAERS: 1US FAERS
40DysphoniaFAERS: 1US FAERS
41Eye painFAERS: 1US FAERS
42Feeling abnormalFAERS: 1SIDER
US FAERS
43FlushingFAERS: 1SIDER
US FAERS
44Foaming at mouthFAERS: 1US FAERS
45Mental impairmentFAERS: 1US FAERS
46Musculoskeletal discomfortFAERS: 1US FAERS
47Nephrotic SyndromeFAERS: 1US FAERS
48Oropharyngeal discomfortFAERS: 1US FAERS
49PetechiaeFAERS: 1US FAERS
50Respiratory distressFAERS: 1SIDER
US FAERS
51RestlessnessFAERS: 1US FAERS
52Retrograde amnesiaFAERS: 1US FAERS
53RhonchiFAERS: 1US FAERS
54ShockFAERS: 1SIDER
US FAERS
55TachyarrhythmiaFAERS: 1US FAERS
56TachycardiaFAERS: 1SIDER
US FAERS
57Throat irritationFAERS: 1US FAERS
58Traumatic fractureFAERS: 1US FAERS
59WheezingFAERS: 1US FAERS
60AgitationSIDER
61AkathisiaSIDER
62Anaphylactic shockSIDER
63AstheniaSIDER
64Back PainSIDER
65ConjunctivitisSIDER
66DermatitisSIDER
67DiscomfortSIDER
68DysgeusiaSIDER
69FatigueSIDER
70Gastrointestinal PainSIDER
71HeadacheSIDER
72HypersensitivitySIDER
73Injection Site ReactionSIDER
74Injection site burningSIDER
75Injection site coldnessSIDER
76Injection site extravasationSIDER
77Injection site irritationSIDER
78Injection site painSIDER
79Nephrogenic Systemic FibrosisSIDER
80PallorSIDER
81PalpitationsSIDER
82RhinitisSIDER
83SneezingSIDER
84TremorSIDER
85VertigoSIDER
86nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.